Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: Significance for living donors

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 3, 2008, Pages 678-684

  Yoshimitsu, Kengo ^a,b,d   Kuroda, Yousuke ^a   Nakamuta, Makoto ^a   Taketomi, Akinobu ^b   Irie, Hiroyuki ^a   Tajima, Tsuyoshi ^a   Hirakawa, Masakazu ^a   Ishigami, Kousei ^a   Ushijima, Yasuhiro ^a   Yamada, Tomomi ^c   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d FUKUOKA UNIVERSITY   (Japan)

Author keywords

Chemical shift MR; Liver; Living donor; Plain CT; Steatosis

Indexed keywords

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER HISTOLOGY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; FATTY LIVER; FEMALE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 51449121612     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21457     Document Type: Article

References (38)

1. Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, et al. Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 1998;22:837-844.
2. Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-1251.
3. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies for the development of primary non-function after orthotopic liver transplantation. Transplantation 1991;51:157-163.
4. Ploeg RJ, D'Alessandro AM. Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813.
5. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-298.
6. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000;32:1280-1288.
7. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001;7:409-414.
8. Rinella ME, Abecassis MM. Liver biopsy in living donors. Liver Transpl 2002;8:1123-1125.
9. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114-1122.
10. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5T vs biopsy. AJR Am J Roentgenol 1991;156:307-312.
11. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113.
12. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol 1983;18: 743-747.
13. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic steatosis disease. Gastroenterology 2002; 123:745-750.
14. Mortele KJ, Ros PR. MR imaging in chronic hepatitis and cirrhosis. Semin Ultrasound CT MR 2002;23:79-100.
15. Cheng YF, Chen CL, Huang TL, et al. Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. Transplantation 2001;72:1527-1533.
16. Cheng YF, Chen CL, Lai CY, et al. Assessment of donor steatosis for liver transplantation. Transplantation 2001;71:1221-1225.
17. Rofsky NM, Fleishaker H. CT and MRI of diffuse liver disease. Semin Ultrasound CT MR 1995;16:16-33.
18. Outwater EK, Blasbalg R, Siegelman ES, Vala M. Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. Radiographics 1998; 18:1465-1480.
19. Sohn J, Siegelman E, Osiason A. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 2001; 176:471-474.
20. Marks SJ, Moore NR, Ryley NG, et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM. Int J Obes Relat Metab Disord 1997;21:274-279.
21. Kreft BP, Tanimoto A, Baba Y, et al. Diagnosis of steatosis with MR imaging. J Magn Reson Imaging 1992;2:463-471.
22. Wenker JC, Baker MK, EllisJH, Glant MD. Focal fatty infiltration of the liver: demonstration by magnetic resonance imaging. AJR Am J Roentgenol 1984;143:573-574.
23. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004;230:276-280.
24. Rinella ME, McCarthy R, Thakrar K, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 2003;9:851-856.
25. Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005;80;608-612.
26. Piperno A, Vergani A, Malosio I, et al. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology 1998;28:1105-1109.
27. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005;25:461-472.
28. Pirisi M, Scott CA, Avellini C, et al. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol 2000;113:546-554.
29. Ramm GA. Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis 2005;25:433-449.
30. Byun JH, Kim TK, Lee SS, et al. Evaluation of the hepatic artery in potential donors for living donor liver transplantation by computed tomography angiography using multidetector-row computed tomography: comparison of volume rendering and maximum intensity projection techniques. J Comput Assist Tomogr 2003;27:125-131.
31. Shinozaki K, Yoshimitsu K, Irie H, et al. Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free precession magnetic resonance imaging. J Comput Assist Tomogr 2004;28:628-634.
32. Breceno J, Padillo J, Ruflan S, Solorzano G, Pera C. Assignment of steatotic liver by the Mayo model for end-stage liver disease. Transpl Int 2005;18:577-583.
33. Nekeghbalian S, Nejatollahi SMR, Salahir H, et al. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation? Transplant Proc 2007;39:1181-1183.
34. Namimoto T, Yamashita Y, Mitsuzaki K, et al. Adrenal masses: quantification of fat content with double-echo chemical shift inphase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology 2001;218:642-646.
35. Yoshimitsu K, Honda H, Kuroiwa T, et al. MR detection of cytoplasmic fat in clear cell renal cell carcinoma using chemical-shift gradient-echo imaging. J Magn Reson Imaging 1999;9:579-585.
36. Yoshimitsu K, Kakihara D, Irie H, et al. Papillary renal carcinoma: diagnostic approach by chemical-shift gradient-echo and echo-planar MR imaging. J Magn Reson Imaging 2006;23:339-344.
37. Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to adult living donor liver transplants using the right lobe. Liver Transpl 2000;6:296-301.
38. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 2005;237:1048-1055.